SRES-746-119
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2428; text: CR S2420-2421)
Sponsored by Steve Daines (R-MT)
What it does
This resolution designates May 2026 as "National Brain Tumor Awareness Month." It encourages public awareness of brain tumors, expresses Senate support for patients and their families, and urges a collaborative approach to brain tumor research. It does not create any programs, appropriate any funds, or impose any legal obligations.
Who benefits
Brain tumor patients and their families, who receive public recognition of their condition. Brain tumor advocacy organizations, which may gain visibility and public engagement during the designated month. Medical researchers working on brain tumor treatments, who may benefit from increased public awareness of the need for research funding. Pediatric cancer communities, given the bill's emphasis on brain tumors as the leading cancer killer of children under 14.
Who is hurt
No group is directly harmed by this resolution. There are no mandates, spending changes, or regulatory effects.
Supporters argue
Supporters argue that brain tumors remain one of the most underfunded and treatment-resistant cancers, with a 5-year survival rate of only 34.8% for malignant cases and mortality rates largely unchanged over 30 years. They contend that a formal Senate designation raises public awareness, encourages advocacy, and signals congressional support for the more than 1 million Americans currently living with a brain tumor diagnosis.
Opponents argue
Opponents might argue that standalone commemorative resolutions consume limited legislative floor time without producing any binding policy change, funding, or measurable improvement in research or patient outcomes. They could contend that the Senate's attention would be better directed toward substantive legislation — such as increased NIH appropriations for brain tumor research — rather than symbolic designations that do not address the treatment gaps the resolution itself acknowledges.
Constitutional context
No significant constitutional issues are raised by this resolution. Commemorative designations are a well-established, non-binding exercise of congressional expression and do not implicate enumerated powers, the Spending Clause, or any active constitutional doctrine.
Checks and balances
The Senate expresses a non-binding opinion; no branch gains or loses authority, and no executive action or judicial review is triggered by this resolution.
Historical precedent
Congress has passed similar commemorative resolutions designating awareness months for other cancers, including National Cancer Awareness Month and disease-specific designations such as National Breast Cancer Awareness Month, establishing a long-standing precedent for this type of non-binding resolution.